Hyderabad Telangana, India

Rajesham Boge

This inventor holds 10 USPTO granted patents and 8 published patent applications. Top assignees: Dr. Reddy's Laboratories, Incorporated, Msn Laboratories Private Limited, Msn Laboratories Private Limited, R&d Center. Active years: 2015-2026.

USPTO Granted Patents = 10 

% Patents Active = 30.0

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Telangana, IN (2020 - 2021)
  • Hyderabad, IN (2015 - 2022)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Rajesham Boge

Introduction: Rajesham Boge, a talented inventor hailing from Hyderabad, India, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Rajesham Boge's latest patents include cutting-edge solutions in the areas of artificial intelligence, renewable energy, and healthcare technology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Rajesham Boge has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of innovation. His dedication to creating solutions that make a difference is evident in the impact of his work.

Collaborations: Throughout his career, Rajesham Boge has collaborated with top scientists, engineers, and researchers from around the globe, fostering a culture of creativity and excellence. His ability to work effectively in multidisciplinary teams has led to the development of groundbreaking technologies.

Conclusion: In conclusion, Rajesham Boge's passion for innovation, coupled with his technical expertise, has established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…